Laura Schoen Named to Medical Marketing & Media’s Second Annual Hall of Femme List
New York – April 11, 2017 – Medical Marketing & Media named Laura Schoen, Weber Shandwick president of Global Healthcare & chair of Latin America, to its 2017 Hall of Femme list. The program honors 16 senior female leaders throughout the biopharma, medical device, diagnostic and agency sectors of the healthcare industry who have made a significant impact in marketing and communications over the past year. Schoen’s tenure in the healthcare communications field spans nearly two decades. Her vast remit ranges from developing and managing programs around pharmaceutical product campaigns, to advising clients on crisis preparedness, corporate positioning and issues management.
“The world of healthcare is growing increasingly complex, but Laura has an expert ability to distill complicated issues into effective creative campaigns that put patients and their wellbeing at the center,” said Andy Polansky, Chief Executive Officer, Weber Shandwick. “I admire Laura’s unwavering curiosity and determination to solve problems. We’re fortunate to have her at the helm of one of our firm’s fastest-growing practice areas.”
Schoen has led the growth of Weber Shandwick’s Global Healthcare practice since joining the firm in 2000, providing strategic counsel and insights to some of the most visible multinational healthcare-related brands in the world. The firm’s global practice spans North America, Europe, Asia and Latin America, with expertise in cardiology, immunology, CNS, oncology, anti-infectives, antivirals, metabolic disorders, eye care, orthopedics, pediatrics, women’s health, medical devices and more.
Under her leadership, Weber Shandwick’s work, in partnership with clients, has been recognized by Lions Health, CLIOS Health, PRWeek, and The Holmes Report. Schoen was recently recognized by PRWeek and MM&M on the inaugural Health Influencer 50 List, which recognized individuals across the health spectrum for their passion, determination and innovative thinking.